Unlike IgG and IgM aCL/aβ2GPI, the role of IgA aCL and IgA aβ2GPI in APS is not yet clear, so IgA antibodies are not included in the current laboratory criteria of APS. This evidence concerns the gene ACLY and autoimmune polyendocrinopathy.